195 related articles for article (PubMed ID: 34950604)
21. [A machine learning model based on initial gut microbiome data for predicting changes of Bifidobacterium after prebiotics consumption].
Luo YM; Liu FT; Chen MX; Tang WL; Yang YL; Tan XL; Zhou HW
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):251-260. PubMed ID: 29643029
[TBL] [Abstract][Full Text] [Related]
22. Gut microbiota in children with juvenile idiopathic arthritis: characteristics, biomarker identification, and usefulness in clinical prediction.
Qian X; Liu YX; Ye X; Zheng W; Lv S; Mo M; Lin J; Wang W; Wang W; Zhang X; Lu M
BMC Genomics; 2020 Apr; 21(1):286. PubMed ID: 32264859
[TBL] [Abstract][Full Text] [Related]
23. Bile acid profiling as an effective biomarker for staging in pediatric inflammatory bowel disease.
Chen W; Wang D; Deng X; Zhang H; Dong D; Su T; Lu Q; Jiang C; Ni Q; Cui Y; Zhao Q; Wang X; Xiao Y; Peng Y
Gut Microbes; 2024; 16(1):2323231. PubMed ID: 38436673
[TBL] [Abstract][Full Text] [Related]
24. A Framework for Effective Application of Machine Learning to Microbiome-Based Classification Problems.
Topçuoğlu BD; Lesniak NA; Ruffin MT; Wiens J; Schloss PD
mBio; 2020 Jun; 11(3):. PubMed ID: 32518182
[TBL] [Abstract][Full Text] [Related]
25. Altered Gut Microbiota Is Present in Newly Diagnosed Pediatric Patients With Inflammatory Bowel Disease.
Sila S; Jelić M; Trivić I; Tambić Andrašević A; Hojsak I; Kolaček S
J Pediatr Gastroenterol Nutr; 2020 Apr; 70(4):497-502. PubMed ID: 31899727
[TBL] [Abstract][Full Text] [Related]
26. [Correlation between Vitamin D Status and Gut Microbiota in Patients with Inflammatory Bowel Disease].
Chen D; Li Y; Sun H; Xiao M; Zhang RL; Qiu L; Tan B; Qian JM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Dec; 42(6):740-748. PubMed ID: 33423720
[TBL] [Abstract][Full Text] [Related]
27. Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease.
Goyal A; Yeh A; Bush BR; Firek BA; Siebold LM; Rogers MB; Kufen AD; Morowitz MJ
Inflamm Bowel Dis; 2018 Jan; 24(2):410-421. PubMed ID: 29361092
[TBL] [Abstract][Full Text] [Related]
28. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
[TBL] [Abstract][Full Text] [Related]
29. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
[TBL] [Abstract][Full Text] [Related]
30. Multi-omics Analysis of Gut Microbiota and Metabolites in Rats With Irritable Bowel Syndrome.
Liu S; Si C; Yu Y; Zhao G; Chen L; Zhao Y; Zhang Z; Li H; Chen Y; Min L; Zhang S; Zhu S
Front Cell Infect Microbiol; 2019; 9():178. PubMed ID: 31192167
[TBL] [Abstract][Full Text] [Related]
31. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
32. The gut fungal and bacterial microbiota in pediatric patients with inflammatory bowel disease introduced to treatment with anti-tumor necrosis factor-α.
Ventin-Holmberg R; Höyhtyä M; Saqib S; Korpela K; Nikkonen A; Salonen A; de Vos WM; Kolho KL
Sci Rep; 2022 Apr; 12(1):6654. PubMed ID: 35459927
[TBL] [Abstract][Full Text] [Related]
33. Gut mucosal-associated microbiota better discloses inflammatory bowel disease differential patterns than faecal microbiota.
Altomare A; Putignani L; Del Chierico F; Cocca S; Angeletti S; Ciccozzi M; Tripiciano C; Dalla Piccola B; Cicala M; Guarino MPL
Dig Liver Dis; 2019 May; 51(5):648-656. PubMed ID: 30573380
[TBL] [Abstract][Full Text] [Related]
34. Management and monitoring of pediatric inflammatory bowel disease in the Asia-Pacific region: A position paper by the Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group: Surgical management, disease monitoring, and special considerations.
Lee WS; Arai K; Alex G; Treepongkaruna S; Kim KM; Choong CL; Mercado KC; Darma A; Srivastava A; Aw MM;
J Gastroenterol Hepatol; 2023 Apr; 38(4):510-522. PubMed ID: 36508314
[TBL] [Abstract][Full Text] [Related]
35. [Effect of
Chen L; Xu WL; Pei LX; Wu XL; Geng H; Guo J; Sun JH
Zhongguo Zhen Jiu; 2021 Feb; 41(2):137-41. PubMed ID: 33788460
[TBL] [Abstract][Full Text] [Related]
36. Automated Fecal Biomarker Profiling - a Convenient Procedure to Support Diagnosis for Patients with Inflammatory Bowel Diseases.
Kraemer A; Bulgakova T; Schukina O; Kharitidis A; Kharitonov A; Korostovtseva E; Hammar F; Bang H; Lapin S
Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658433
[TBL] [Abstract][Full Text] [Related]
37. Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer.
Deng T; Li J; He B; Chen B; Liu F; Chen Z; Zheng J; Shi Z; Zhang T; Deng L; Yu H; Yang J; Wu L; Shan Y; Yu Z; Chen X; Wang Y; Chen G
Hepatol Int; 2022 Feb; 16(1):99-111. PubMed ID: 35064546
[TBL] [Abstract][Full Text] [Related]
38. Gut Microbiome Analysis Can Be Used as a Noninvasive Diagnostic Tool and Plays an Essential Role in the Onset of Membranous Nephropathy.
Shang J; Zhang Y; Guo R; Liu W; Zhang J; Yan G; Wu F; Cui W; Wang P; Zheng X; Wang T; Dong Y; Zhao J; Wang L; Xiao J; Zhao Z
Adv Sci (Weinh); 2022 Oct; 9(28):e2201581. PubMed ID: 35975460
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of Machine Learning-Based Gut Microbiome Analysis for Identifying Patients with Irritable Bowels Syndrome.
Fukui H; Nishida A; Matsuda S; Kira F; Watanabe S; Kuriyama M; Kawakami K; Aikawa Y; Oda N; Arai K; Matsunaga A; Nonaka M; Nakai K; Shinmura W; Matsumoto M; Morishita S; Takeda AK; Miwa H
J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32727141
[TBL] [Abstract][Full Text] [Related]
40. Mucosa-Associated Microbiota in Patients with Irritable Bowel Syndrome: A Comparison of Subtypes.
Matsumoto H; Shiotani A; Katsumata R; Fukushima S; Handa Y; Osawa M; Murao T; Handa O; Umegaki E; Inoue R; Naito Y
Digestion; 2021; 102(1):49-56. PubMed ID: 33271532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
